Status
Conditions
Treatments
About
The purpose of this study is to test whether prophylactic application of haemostatic gel will reduce the rate of clinically significant bleeding requiring intervention (such as blood transfusion, admission to hospital, other blood products) following endoscopic resection of advanced duodenal neoplasia compared to standard therapy.
Full description
This is a post-marketing follow-up study of a CE marked medical device, controlled, comparative, randomized, multicentre, international single-blind.
The main objective is to evaluate the efficacy and safety of PuraStat in duodenal endoscopic mucosal resection or ampullectomy.
This study will be carried out in France in 3 investigative centers. The duration of patient participation in the study is approximately 37 days depending on the time between the selection and the endoscopic intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Ampullary lesions
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
234 participants in 2 patient groups
Loading...
Central trial contact
Sarah LEBLANC, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal